《大行報告》大華繼顯降敏實(00425.HK)目標價至20元 行業增長放緩
大華繼顯發表報告指,敏實集團(00425.HK)去年下半年業務未有受到去年11月初結束的美國汽車工人聯合會(UAW)罷工的影響,只有小部分訂單由去年下半年延後至今年上半年,料其去年下半年收入錄得按年及按半年增長。
該行指,與電動車相關的新項目增加、其擴大客戶群並納入更多中國汽車製造商等因素,均推動敏實收入增長;但全球電動車銷售放緩和價格戰加劇,均拖累其盈利增長。
大華繼顯表示,維持其去年每股盈測為1.69元人民幣、今明兩年則分別下調8%及11%,至1.87元人民幣和2.16元人民幣。考慮訂單強勁但行業增長放緩,該行將其目標價由33元下調至20元,維持「買入」評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.